Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6126
CALL
Direxion Daily Real Estate Bear 3X ETF
DRV
$26.5M
| $8K | ﹤0.01% |
+14
| New | +$7.77K |
|
|
DX
6127
Dynex Capital
DX
$3.15B
| $8K | ﹤0.01% |
356
+49
| +16% | +$1.04K |
|
|
EBTC
6128
DELISTED
Enterprise Bancorp
EBTC
| $8K | ﹤0.01% |
219
+215
| +5,375% | +$7.32K |
|
|
EEX
6129
DELISTED
Emerald Holding
EEX
| $8K | ﹤0.01% |
362
-719
| -67% | -$15.9K |
|
6130
iShares MSCI EAFE Growth ETF
EFG
$16.6B
| $8K | ﹤0.01% |
+99
| New | +$7.5K |
|
6131
Enphase Energy
ENPH
$4.96B
| $8K | ﹤0.01% |
5,000
| – | – |
|
6132
Primis Financial Corp
FRST
$399M
| $8K | ﹤0.01% |
498
+491
| +7,014% | +$8.23K |
|
6133
CALL
Geron
GERN
$828M
| $8K | ﹤0.01% |
3,800
-8,200
| -68% | -$19.3K |
|
|
GNTY
6134
DELISTED
Guaranty Bancshares
GNTY
| $8K | ﹤0.01% |
275
+163
| +146% | +$4.57K |
|
6135
Standard BioTools
LAB
$340M
| $8K | ﹤0.01% |
1,723
-12,979
| -88% | -$54.6K |
|
6136
Lineage Cell Therapeutics
LCTX
$269M
| $8K | ﹤0.01% |
3,146
+1,942
| +161% | +$4.82K |
|
6137
Lloyds Banking Group
LYG
$89.5B
| $8K | ﹤0.01% |
2,050
-500,000
| -100% | -$1.74M |
|
6138
CALL
Main Street Capital
MAIN
$5.06B
| $8K | ﹤0.01% |
+200
| New | +$7.86K |
|
6139
MediciNova
MNOV
$65.5M
| $8K | ﹤0.01% |
1,188
+914
| +334% | +$4.86K |
|
6140
NRC Health Common Stock
NRC
$432M
| $8K | ﹤0.01% |
220
+214
| +3,567% | +$6.72K |
|
6141
Option Care Health
OPCH
$3.45B
| $8K | ﹤0.01% |
724
-8,878
| -92% | -$100K |
|
6142
Peoples Financial Services
PFIS
$704M
| $8K | ﹤0.01% |
159
+154
| +3,080% | +$6.6K |
|
6143
Pixelworks
PXLW
$38.2M
| $8K | ﹤0.01% |
130
+128
| +6,400% | +$7.21K |
|
6144
PUT
RadNet
RDNT
$5.02B
| $8K | ﹤0.01% |
+700
| New | +$6.4K |
|
6145
Sonida Senior Living
SNDA
$1.91B
| $8K | ﹤0.01% |
41
-1,077
| -96% | -$211K |
|
6146
PUT
Supernus Pharmaceuticals
SUPN
$2.59B
| $8K | ﹤0.01% |
+200
| New | +$8.65K |
|
6147
PUT
Telephone and Data Systems
TDS
$3.82B
| $8K | ﹤0.01% |
300
-2,000
| -87% | -$56.5K |
|
6148
TETRA Technologies
TTI
$1.14B
| $8K | ﹤0.01% |
2,654
-32,583
| -92% | -$79.9K |
|
6149
CALL
Yum China
YUMC
$16.5B
| $8K | ﹤0.01% |
200
| – | – |
|
6150
Arq
ARQ
$84.6M
| $8K | ﹤0.01% |
756
-4,917
| -87% | -$49.4K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.